View Post

Is it time to say goodbye to ClinicalTrials.Gov?

In In The News by Barbara Jacoby0 Comments

By: Zikria Syed From: medcitynews.com It is an exciting time in the pharmaceutical industry. According to industry organization PHRMA, there are currently more than 7,000 new medicines under development with many being first in class treatments. Digital technology combined with medicine, gene therapy and personalized medicine are driving a lot of this. However, to bring these treatments to market, clinical trials …

View Post

Cancer clinical trials exclude many desperate patients – should that change?

In In The News by Barbara Jacoby0 Comments

By: Aimee Swartz, Special To The Washington Post From: chicagotribune.com When 29-year-old Carly Bastiansen was diagnosed in January 2016 with advanced pancreatic cancer, doctors told her a clinical trial was her best shot at slowing the notoriously quick-killing and hard-to-treat disease. She found one that appeared promising and went through the screening process. But the trial would not accept her. …

View Post

Clinical trials are under fire, but as doctor with a rare cancer, I’m glad they exist

In In The News by Barbara Jacoby0 Comments

By: Beth W. Rackow, MD From: qz.com Cancer is rarely far from the front page, and it recently added one more prominent member to the club. Already having returned to work, Arizona senator John McCain has not let his glioblastoma diagnosis slow him down. I respect McCain for his willingness to share his diagnosis so quickly, so publicly, and at …

View Post

Blacks, Elderly Missing From U.S. Cancer Clinical Trials

In In The News by Barbara Jacoby0 Comments

From: drugs.com Four out of five participants in cancer clinical trials are white, a discrepancy that calls into question whether other races and ethnicities are receiving good cancer treatment, researchers say. Women and the elderly also are underrepresented in clinical trials, according to the new findings. Prior studies have shown that the effectiveness of cancer treatment can vary based on …

View Post

Breast cancer in a new light: Injection makes cancer cells glow, easier for doctors to see

In In The News by Barbara Jacoby0 Comments

By: Caroline Balchunas From: abcnews4.com Lowcountry doctors are seeing breast cancer in a new light. New technology—an injection—is making cancer easier to spot and easier to treat. Before undergoing surgery to remove the tumor, patients receive an injection. The formula creates chemical reaction, which illuminates the bad cancer cells. Last week, Dr. Paul Baron, a surgical oncologist with Roper St. …

View Post

How to Find a Clinical Trial: Questions and Tips for Cancer Patients

In In The News by Barbara Jacoby0 Comments

By: Stav Ziv From: newsweek.com Clinical trials aren’t for every cancer patient. But for some, experimental new treatments can provide hope for a better outcome than standard methods provide. Newsweek spoke with Dr. Sheila Prindiville—a medical oncologist and director of the National Cancer Institute’s (NCI) Coordinating Center for Clinical Trials—about some of the basics, like when cancer patients might want …

View Post

Cancer Patients and Caregivers Join Immunotherapy Experts in Five U.S. Cities to Discuss Latest Cancer Treatment Breakthroughs and Immunotherapy Clinical Trials

In In The News by Barbara Jacoby0 Comments

Registration now open for free, half-day programs in San Francisco, Chicago, New York City, Houston, and Tampa The Cancer Research Institute (CRI), the world’s leading nonprofit organization dedicated exclusively to advancing scientific efforts to develop new and effective immunotherapies for all forms of cancer, announced today that its 2017 Immunotherapy Patient Summit Series will travel to five U.S. cities to …

View Post

Clinical Trials for Colon Cancer

In In The News by Barbara Jacoby0 Comments

By: Kathleen Hall From: usnews.com Are you currently undergoing treatment for colon cancer? If so, you should know that any drug your doctor prescribed went through rigorous testing and evaluation before it became widely available to patients. After a drug shows significant potential in the lab, researchers study it in clinical trials. There are three phases of clinical trials: Early …

View Post

Lehi biotech company developing cancer treatment drug

In In The News by Barbara Jacoby0 Comments

By: Jason Lee From: deseretnews.com David Bearss doesn’t remember his grandfather. The family patriarch was in his 40s when he was diagnosed with colon cancer in 1969 — the year Bearss was born. He died before Bearss was old enough to know him. “I have pictures of him holding me as a baby,” Bearss said. “But with cancer in those …

View Post

Ohio State ramping up research on cancer drugs

In In The News by Barbara Jacoby0 Comments

By: JoAnne Viviano From: dispatch.com Researchers at an Ohio State University institute that seeks to move prospective cancer therapies from the lab to the patient have targeted six projects to focus on this year. The Drug Development Institute, buoyed by funds from the Pelotonia bicycling tour and the philanthropic Harry T. Mangurian Jr. Foundation, hopes to help scientists bring novel …